This high rate of fibrosis is apparently link to the existence of a more active HCV infection supported by HIV-induced CD4+ T cell loss that deregulates T cell function leading to reduced anti-fibrotic activity of NK cells, resulting in accelerated progression of liver fibrosis in HIV/HCV co-infected participants [21, 22]. Here, CD4 is linked to Hepatic fibrosis.